pharma · PTIX
Protagenic Therapeutics, Inc.new
Protagenic Therapeutics, Inc.new patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
NEW YORK, NY, USA HQ
1 Employees
Public company Type
PTIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, USA
- Employees
- 1
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Protagenic Therapeutics, Inc.new patents
0 pharmaceutical patents indexed for Protagenic Therapeutics, Inc.new. 0 expire within 24 months.
Protagenic Therapeutics, Inc.new has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Protagenic Therapeutics, Inc.new have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Protagenic Therapeutics, Inc.new patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.